07 Mar 2025 Avacta Announces Agreement to Sell Launch Diagnostics and a Corporate Update Diagnostics | Investors
01 Jun 2023 Avacta acquires Coris Bioconcept, adding a broad range of marketed professional-use rapid tests to the Group Diagnostics | Investors
10 Jan 2022 Update on AffiDX® SARS-CoV-2 antigen lateral flow test and detection of the Omicron variant Diagnostics | Investors
22 Dec 2021 AffiDX® SARS-CoV-2 Antigen Lateral Flow Test Receives CE Mark for Consumer Self-Testing Diagnostics | Investors
15 Dec 2021 AffiDX® SARS-CoV-2 antigen lateral flow test detects the Omicron variant Diagnostics | Investors
02 Nov 2021 Update on UK Availability of AffiDX® SARS-CoV-2 Lateral Flow Rapid Antigen Test following Implementation of CTDA Regulations Diagnostics | Investors